Alpha Cognition Inc. ACOG

Competitive advantage analysis · healthcare

Corporate Default
Overall moat score
45/100
Developing

Ranked against 712 peers in Biotechnology

About Alpha Cognition Inc.

Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer's disease; ALPHA-1062 sublingual formulation for acute … Full ACOG analysis →

Key strengths

  • Strong Liquidity Buffer Liquidity position is strong (score 0.75), providing operational cushion.
  • Operating Expense Control OpEx growth is controlled (score 0.64), demonstrating operating leverage.

Key risks

  • Commodity Pressure / Weak Differentiation Gross margin at 38.2th percentile with high volatility suggests weak pricing power or commoditized products.
  • Revenue Volatility Signals Weak Stickiness Revenue volatility is high (stability score 0.00), suggesting weak customer stickiness.

The dashed ring is the peer median. Defense scores are percentile ranks against peers, so 50 is roughly the typical company in this group.

Upgrade to unlock the signals and evidence behind each defense.

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power

Developing
26
Premium

Signals, strengths and risks for Pricing Power

Premium

Signals, strengths and risks for Cost Advantage

Premium

Signals, strengths and risks for Customer Stickiness

Premium

Signals, strengths and risks for Capital Efficiency

Premium

Signals, strengths and risks for Resilience

Premium

Signals, strengths and risks for Scale & Market Position

Where ACOG ranks in Biotechnology

Alpha Cognition Inc. ranks #302 of 713 scored companies in Biotechnology by moat score — the top 42%. The widest moat in the group is Royalty Pharma plc (RPRX) at 85/100.

# Company Moat score Rating
298 Kyverna Therapeutics, Inc. KYTX 45/100 Developing
299 Vir Biotechnology, Inc. VIR 45/100 Developing
300 Sagimet Biosciences Inc. - Seri SGMT 45/100 Developing
301 Ventyx Biosciences, Inc. VTYX 45/100 Developing
302 Alpha Cognition Inc. ACOG 45/100 Developing
303 Alterity Therapeutics Limited ATHE 45/100 Developing
304 EyePoint Pharmaceuticals, Inc. EYPT 45/100 Developing
305 Aptevo Therapeutics Inc. APVO 45/100 Developing
306 Orchestra BioMed Holdings, Inc. OBIO 45/100 Developing

See every Biotech / Pre-Revenue company ranked by moat score →

How ACOG scores on the Corporate Default defenses

Pricing Power

Score 26 · 20% of the moat score

Pricing power is the ability to raise prices without losing volume.

Cost Advantage

Score 54 · 15% of the moat score

A cost advantage means delivering the same product for structurally less — better purchasing, denser distribution, a more automated process.

Customer Stickiness

Score 62 · 15% of the moat score

Stickiness is what makes revenue repeat without being re-won every year.

Capital Efficiency

Score 28 · 18% of the moat score

Capital efficiency asks what the company earns on the money tied up in the business.

Resilience

Score 55 · 17% of the moat score

Resilience is the capacity to get through a bad year on its own terms — enough liquidity, enough interest cover, and enough cash generation to avoid a rescue financing or a forced sale.

Scale & Market Position

Score 51 · 15% of the moat score

Scale matters only when it converts into economics.

How each Corporate Default defense is measured, in full →

Understanding ACOG's moat

What is Alpha Cognition Inc.'s moat score?

Alpha Cognition Inc. (ACOG) scores 45 out of 100 on the StatsAlpha Moat Map, which rates its competitive advantage as developing. It ranks #302 of 713 scored companies in Biotechnology, the top 42%. The score is a weighted composite of 6 competitive defenses, each measured against industry peers of 712 companies in Biotechnology. Its strongest defense is Customer Stickiness (62/100) and its weakest is Pricing Power (26/100).

How does Alpha Cognition Inc. compare with other Biotechnology companies?

Alpha Cognition Inc. ranks #302 of 713 scored companies in Biotechnology by moat score. The widest moat in Biotechnology is Royalty Pharma plc (RPRX) at 85/100. The companies ranked closest are Ventyx Biosciences, Inc. (VTYX) at 45 just above it and Alterity Therapeutics Limited (ATHE) at 45 just below it.

How is the moat score calculated?

Each company is scored with an industry-specific template — Corporate Default in this case, chosen because the defenses that matter to a bank are not the ones that matter to a software company. Every defense combines several financial signals, and each signal is measured as a percentile against a peer group of 712 companies in Biotechnology. The defenses are then weighted to produce the overall score out of 100.

Why is Alpha Cognition Inc. scored with the Corporate Default template?

Most public companies sell a product or a service at a margin, so the moat question is whether that margin survives contact with competitors. The Corporate template scores the six defenses that show up in a general operating company's financial signature: whether it can hold price, produce more cheaply than rivals, keep its customers, earn a return above its cost of capital, withstand a downturn, and turn size into economics.

Which competitive defenses are measured for Alpha Cognition Inc.?

The Corporate Default template measures 6 defenses, and ACOG scores: Pricing Power (26), Cost Advantage (54), Customer Stickiness (62), Capital Efficiency (28), Resilience (55), Scale & Market Position (51). Each is scored independently as a percentile against peers, so a company can be strong on one and weak on another — the overall score reflects how those defenses are weighted for this industry.

Send Feedback
Please select a category.
0/1000